Thalidomide Celgene-H-C-PSUSA-00002919-201810: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Thalidomide Celgene-H-C-PSUSA-00002919-201810: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Zaawansowana formuła farmaceutyczna do celowanego działania terapeutycznego.
Dawkowanie
Thalidomide Celgene-H-C-PSUSA-00002919-201810: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Moc
Thalidomide Celgene-H-C-PSUSA-00002919-201810: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Wielkość opakowania
Thalidomide Celgene-H-C-PSUSA-00002919-201810: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Postać
Thalidomide Celgene-H-C-PSUSA-00002919-201810: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Źródło
European Medicines Agency
